Supporting the first Hong Kong Global Cancer IP Investors Forum

The Hong Kong Global Cancer IP Investors Forum 2025, hosted by the Global Cancer IP Promotion Alliance at The Chinese University of Hong Kong. This prestigious platform unites global leaders in cancer research, intellectual property, and investment to drive transformative advancements in oncology, serving as a catalyst for innovation with strategic discussions on IP commercialization, funding opportunities, and groundbreaking research.
 
The HSITP ecosystem empowers technology companies by connecting them with our intellectual property experts and partners to navigate government IP funding, facilitate IP valuation for investments, and foster collaborations with universities and corporations. Through these efforts, we strengthen IP protection, drive commercialization, and enhance innovation, ensuring sustained growth and competitiveness in the technology sector.
 
By leveraging innovation and investment, HSITP aims to shape the future of sustainable life science innovations and to tackle global healthcare challenges. We are excited to engage with distinguished experts, exchange insights, and forge partnerships that propel advancements in cancer research and IP commercialization. Join us in building a dynamic ecosystem that transforms innovative research into life-saving solutions!